Immutep receives A$856,669 R&D tax rebate from Australia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Immutep receives A$856,669 R&D tax rebate from Australia

Immutep Receives ~A$0.86 Million R&D Tax Incentive

September 30, 2026 8:00 AM EDT

SYDNEY, AUSTRALIA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces that it received an A$856,669 cash rebate from the Australian Federal Governments R&D tax incentive program. The cash rebate was provided in respect of expenditure incurred on eligible R&D activities... More